|
1
|
Wasser WG, Krakoff LR, Haimov M, Glabman S
and Mitty HA: Restoration of renal function after bilateral renal
artery occlusion. Arch Intern Med. 141:1647–1651. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Devarajan P: Update on mechanisms of
ischemic acute kidney injury. J Am Soc Nephrol. 17:1503–1520. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharfuddin AA and Molitoris BA:
Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol.
7:189–200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ali T, Khan I, Simpson W, Prescott G,
Townend J, Smith W and Macleod A: Incidence and outcomes in acute
kidney injury: A comprehensive population-based study. J Am Soc
Nephrol. 18:1292–1298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lenaerts K, Ceulemans LJ, Hundscheid IH,
Grootjans J, Dejong CH and Damink Olde SW: New insights in
intestinal ischemia-reperfusion injury: Implications for intestinal
transplantation. Curr Opin Organ Transplant. 18:298–303. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Salvadori M, Rosso G and Bertoni E: Update
on ischemia-reperfusion injury in kidney transplantation:
Pathogenesis and treatment. World J Transplant. 5:52–67.
2015.PubMed/NCBI
|
|
7
|
Menke J, Sollinger D, Schamberger B,
Heemann U and Lutz J: The effect of ischemia/reperfusion on the
kidney graft. Curr Opin Organ Transplant. 19:395–400. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Friedewald JJ and Rabb H: Inflammatory
cells in ischemic acute renal failure. Kidney Int. 66:486–491.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ysebaert DK, De Greef KE, De Beuf A, Van
Rompay AR, Vercauteren S, Persy VP and De Broe ME: T cells as
mediators in renal ischemia/reperfusion injury. Kidney Int.
66:491–496. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thurman JM: Triggers of inflammation after
renal ischemia/reperfusion. Clin. Immunol. 123:7–13. 2007.
|
|
11
|
Garcia-Criado FJ, Eleno N, Santos-Benito
F, Valdunciel JJ, Reverte M, Lozano-Sánchez FS, Ludeña MD,
Gomez-Alonso A and López-Novoa JM: Protective effect of exogenous
nitric oxide on the renal function and inflammatory response in a
model of ischemia-reperfusion. Transplantation. 66:982–990. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shingu C, Koga H, Hagiwara S, Matsumoto S,
Goto K, Yokoi I and Noguchi T: Hydrogen-rich saline solution
attenuates renal ischemia-reperfusion injury. J Anesth. 24:569–574.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Yu G, Liu SY, Li JB, Wang JF, Bo
LL, Qian LR, Sun XJ and Deng XM: Hydrogen-rich saline protects
against renal ischemia/reperfusion injury in rats. J Surg Res.
167:e339–e344. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pearson G, Robinson F, Gibson Beers T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Terada Y, Inoshita S, Kuwana H, Kobayashi
T, Okado T, Ichijo H and Sasaki S: Important role of apoptosis
signal-regulating kinase 1 in ischemic acute kidney injury. Biochem
Biophys Res Commun. 364:1043–1049. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
El-Mas MM, El-Gowelli HM, Ghazal AR,
Harraz OF and El-Din Mohy MM: Facilitation of central imidazoline
I(1)-site/extracellular signal-regulated kinase/p38
mitogen-activated protein kinase signalling mediates the
hypotensive effect of ethanol in rats with acute renal failure. Br
J Pharmacol. 158:1629–1640. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Irving EA and Bamford M: Role of mitogen-
and stress-activated kinases in ischemic injury. J Cereb Blood Flow
Metab. 22:631–647. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaminska B: MAPK signalling pathways as
molecular targets for anti-inflammatory therapy-from molecular
mechanisms to therapeutic benefits. Biochim Biophys Acta.
1754:253–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guining Wei: Evodia rutaecarpa. Shen
Nong's Herbal Classic Beijing: Military Medical Science Press; pp.
902015
|
|
20
|
Hou X, Yu Z, Xu Z, Wang Y and Dai F:
Determination of the Contents of Evodiamine and Rutaecarpine in 34
Species of Evodia Rutaecarpa by HPLC. J Shenyang Pharm Univ.
17:334–337. 2000.
|
|
21
|
Yu Q, Guo C and Cheng Z: Current advances
in the study on rutaecarpine. Yaoxue Shijian Zazhi. 25:353–357.
2007.
|
|
22
|
Hu CP and Li YJ: Research progress in
pharmacological actions of evodiamine and rutaecarpine. Zhongguo
Yaolixue Tongbao. 19:1084–1087. 2003.
|
|
23
|
Lee SH, Son JK, Jeong BS, Jeong TC, Chang
HW, Lee ES and Jahng Y: Progress in the studies on rutaecarpine.
Molecules. 13:272–300. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mutlu G, Abbasoğlu L, Doğru-Abbasoğlu S,
Solakoğlu S and Bulut M: Morphologic changes and lipid peroxidation
in renal tissues of young rats following intestinal
ischemia-reperfusion. Pediatr Surg Int. 18:337–340. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McWhinnie DL, Thompson JF, Taylor HM,
Chapman JR, Bolton EM, Carter NP, Wood RF and Morris PJ:
Morphometric analysis of cellular infiltration assessed by
monoclonal antibody labeling in sequential human renal allograft
biopsies. Transplantation. 42:352–358. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang S, Chou WP and Pei L: Effects of
propofol on renal ischemia/reperfusion injury in rats. Exp Ther
Med. 6:1177–1183. 2013.PubMed/NCBI
|
|
27
|
Trof RJ, Di Maggio F, Leemreis J and
Groeneveld AB: Biomarkers of acute renal injury and renal failure.
Shock. 26:245–253. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Di Grande A, Giuffrida C, Carpinteri G,
Narbone G, Pirrone G, Di Mauro A, Calandra S, Noto P, Le Moli C,
Alongi B and Nigro F: Neutrophil gelatinase-associated lipocalin: A
novel biomarker for the early diagnosis of acute kidney injury in
the emergency department. Eur Rev Med Pharmacol Sci. 13:197–200.
2009.PubMed/NCBI
|
|
29
|
Makris K and Spanou L: Acute kidney
injury: Definition, pathophysiology and clinical phenotypes. Clin
Biochem Rev. 37:85–98. 2016.PubMed/NCBI
|
|
30
|
Oguz E, Yilmaz Z, Ozbilge H, Baba F, Tabur
S, Yerer MB and Hekimoglu A: Effects of melatonin on the serum
levels of pro-inflammatory cytokines and tissue injury after renal
ischemia reperfusion in rats. Ren Fail. 37:318–322. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McCullough JW, Renner B and Thurman JM:
The role of the complement system in acute kidney injury. Semin
Nephrol. 33:543–556. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gutteridge JM and Halliwell B: The
measurement and mechanism of lipid peroxidation in biological
systems. Trends Biochem Sci. 15:129–135. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tábara LC, Poveda J, Martin-Cleary C,
Selgas R, Ortiz A and Sanchez-Niño MD: Mitochondria-targeted
therapies for acute kidney injury. Expert Rev Mol Med. 16:e132014.
View Article : Google Scholar : PubMed/NCBI
|
